Guwahati: One of the potential vaccines against COVID-19 by AstraZeneca, the AstraZeneca plcAZN.L (AZN.L) will provide protection against contracting the infectious virus for only a year. This was told by Pascal Soriot, the CEO of the company on Tuesday, June 16.
The British drugmaker has already started the human trials of the vaccine. The vaccine is created by the University of Oxford, with phase I of the trial in Britain to end soon and phase III trial already making its headway as stated by Soriot.
Also Read: Low-cost steroid Dexamethasone found to reduce COVID-19 deaths
...
Trending Stories
- Malaysian footballer targeted in acid attack in Kuala Lumpur
- Veteran British actor Bernard Hill passes away at 79
- No directive from MHA to seal Indo-Myanmar border: Mizoram CM
- Manipur: Lightning strike kills onee; schools, colleges shut for safety
- Mizoram’s Chhangte, Ralte lead Mumbai City FC to ISL Glory
- RPF urges NE youth to seize job opportunities in rail security
